Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 26;18(1):73.
doi: 10.1186/s12931-017-0559-0.

Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma

Umme Kolsum  1   2 , Arjun Ravi  3   4 , Paul Hitchen  4 , Satyanarayana Maddi  3 , Thomas Southworth  3 , Dave Singh  3   4
Affiliations

Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma

Umme Kolsum et al. Respir Res. .

Abstract

Eosinophilic COPD appears to be a distinct patient subgroup with an increased corticosteroid response. Eosinophilic COPD has been labelled as part of the asthma COPD overlap syndrome (ACOS). We compared the clinical characteristics of eosinophilic COPD patients (without any clinical history of asthma) and COPD patients with a childhood history of asthma. COPD patients with asthma were characterised by more allergies and more exacerbations, but less eosinophilic inflammation. While terms such as "ACOS" are used to "lump" patients together, we report distinct differences between eosinophilic COPD and COPD patients with asthma, and propose that these groups should be split rather than lumped.

Keywords: ACOS; Asthma COPD overlap; COPD; Eosinophils.

PubMed Disclaimer

References

    1. Brightling CE, McKenna S, Hargadon B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. 2005;60(3):193–8. doi: 10.1136/thx.2004.032516. - DOI - PMC - PubMed
    1. Siddiqui SH, Guasconi A, Vestbo J, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(4):523–5. doi: 10.1164/rccm.201502-0235LE. - DOI - PMC - PubMed
    1. Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44(6):1697–700. doi: 10.1183/09031936.00162414. - DOI - PubMed
    1. Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG. Blood Eosinophils and Exacerbations in COPD: the Copenhagen General Population Study. Am J Respir Crit Care Med. 2015 - PubMed
    1. Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med. 2015;21(1):74–9. doi: 10.1097/MCP.0000000000000118. - DOI - PubMed

MeSH terms